Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Francesca Stefini"'
Autor:
Mauro Panteghini, Mario Toppino, Paolo Hoffer, Gianmatteo Micca, Giancarlo Zucchelli, Luigi Romano, Franca Pagani, Fabio Manoni, Francesca Stefini, Annalisa Iervasi, Romolo M. Dorizzi, Marco Caputo
Publikováno v:
Clinical Chemistry. 50:1707-1709
The redefined biochemical criterion proposed to diagnose myocardial infarction (MI) necessitates the availability of highly sensitive and precise cardiac troponin assays (1). In general, a substantial improvement in the analytical performance is offe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a22f6e496a8e227a8f8a7ef128ca219
https://doi.org/10.1373/clinchem.2004.035451
https://doi.org/10.1373/clinchem.2004.035451
Autor:
Mauro Panteghini, Raffaele Giubbini, Graziella Bonetti, Franca Pagani, Francesca Stefini, Claudio Cuccia
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 43
Few studies have evaluated cardiac troponin I (cTnI) as a marker for infarct size and left ventricular (LV) dysfunction. Here we investigated the ability of a single-point cTnI, measured with a second-generation assay (Access AccuTnI), to estimate in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a45fccab473f17a473783d7c0dde74cf
https://doi.org/10.1515/cclm.2005.143
https://doi.org/10.1515/cclm.2005.143
Publikováno v:
Clinical chemistry. 50(7)
Cardiac troponin has been designated as the preferred biomarker for diagnosis of myocardial infarction (MI) (1). Previously published data, however, confirm the large diversity among cardiac troponin assays with respect to important analytical charac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d85db406fac9dad49661e6807b2e6e45
https://pubmed.ncbi.nlm.nih.gov/15229167
https://pubmed.ncbi.nlm.nih.gov/15229167
Autor:
Jean-Paul Chapelle, Jutta Engelmayer, Franca Pagani, Mauro Panteghini, Hilmar Luthe, Francesca Stefini, Guillaume Lefevre, Hanafi Graine
Publikováno v:
Clinical biochemistry. 37(9)
Objectives: This study evaluated the analytical characteristics of the LiaisonR immunoassay for cardiac troponin I (cTnI). Design and methods: The protocol consisted of eight sections: evaluation of antibody specificity, linearity, detection limit an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd16edfc830a6d8b84695f578cca326a
https://pubmed.ncbi.nlm.nih.gov/15329312
https://pubmed.ncbi.nlm.nih.gov/15329312
Publikováno v:
Clinical chemistry and laboratory medicine. 38(11)
The measurement of the degradation product of the C-telopeptide of type I collagen in serum (s-βCTX) has been evaluated in the form of an automated chemiluminometric assay. The between-day coefficients of variation ranged between 2.6 and 6.0% over t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92e59221e2d3baa570e2f6ffb2902cca
https://pubmed.ncbi.nlm.nih.gov/11156338
https://pubmed.ncbi.nlm.nih.gov/11156338
Publikováno v:
Clinical chemistry. 46(7)
The ACS:180® immunoassay system (Bayer Diagnostics) is an automated random analyzer that uses acridinium ester-based chemiluminescence detection. The architecture of the cardiac marker assays is a heterologous sandwich format, using monoclonal anti-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92ec8b361b87399819960a801419eeec
https://pubmed.ncbi.nlm.nih.gov/10894856
https://pubmed.ncbi.nlm.nih.gov/10894856
Publikováno v:
Clinical Chemistry and Laboratory Medicine. 38
The availability of specific markers of myocardial damage has focused attention on the decision limits to be used in clinical practice. These markers can be employed in the diagnosis of myocardial infarction and risk stratification in patients with a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::794f38dd47e80fae48d29cc044a11860
https://doi.org/10.1515/cclm.2000.176
https://doi.org/10.1515/cclm.2000.176